NEUE
NEUE
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $209.082M ▼ | $48.415M ▼ | $-23.501M ▼ | -11.24% ▼ | $-2.63 ▲ | $17.25M ▲ |
| Q1-2025 | $215.787M ▼ | $52.232M ▼ | $-11.739M ▼ | -5.44% ▼ | $-2.9 ▼ | $8.869M ▲ |
| Q4-2024 | $232.638M ▼ | $77.163M ▲ | $-2.722M ▲ | -1.17% ▲ | $-1.94 ▲ | $-33.302M ▼ |
| Q3-2024 | $232.933M ▲ | $67.582M ▼ | $-57.414M ▲ | -24.648% ▲ | $-8.51 ▲ | $-14.297M ▲ |
| Q2-2024 | $225.991M | $85.859M | $-58.63M | -25.944% | $-8.65 | $-31.358M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $145.564M ▲ | $743.689M ▼ | $1.137B ▼ | $-448.784M ▼ |
| Q1-2025 | $145.105M ▲ | $895.68M ▲ | $1.289B ▲ | $-440.741M ▼ |
| Q4-2024 | $93.166M ▼ | $544.383M ▼ | $930.491M ▼ | $-434.688M ▼ |
| Q3-2024 | $118.681M ▼ | $696.783M ▼ | $1.009B ▼ | $-430.399M ▼ |
| Q2-2024 | $142.16M | $897.265M | $1.18B | $-386.405M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.548M ▲ | $-2.826M ▲ | $-8.526M ▼ | $-547K ▲ | $-11.899M ▼ | $-4.453M ▲ |
| Q1-2025 | $-2.329M ▲ | $-21.049M ▲ | $63.176M ▲ | $-2.702M ▲ | $39.425M ▲ | $-22.075M ▲ |
| Q4-2024 | $-47.725M ▲ | $-24.394M ▼ | $2.394M ▲ | $-19.008M ▼ | $-41.008M ▼ | $-25.185M ▼ |
| Q3-2024 | $-56M ▲ | $-21.675M ▲ | $-51K ▲ | $-13.319M ▼ | $-35.045M ▼ | $-22.34M ▲ |
| Q2-2024 | $-57.698M | $-28.431M | $-9.106M | $49.565M | $12.028M | $-29.244M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Capitated Revenue | $70.00M ▲ | $120.00M ▲ | $80.00M ▼ | $80.00M ▲ |
 Service Revenue | $10.00M ▲ | $30.00M ▲ | $10.00M ▼ | $10.00M ▲ |
About NeueHealth, Inc.
https://www.neuehealth.comNeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $209.082M ▼ | $48.415M ▼ | $-23.501M ▼ | -11.24% ▼ | $-2.63 ▲ | $17.25M ▲ |
| Q1-2025 | $215.787M ▼ | $52.232M ▼ | $-11.739M ▼ | -5.44% ▼ | $-2.9 ▼ | $8.869M ▲ |
| Q4-2024 | $232.638M ▼ | $77.163M ▲ | $-2.722M ▲ | -1.17% ▲ | $-1.94 ▲ | $-33.302M ▼ |
| Q3-2024 | $232.933M ▲ | $67.582M ▼ | $-57.414M ▲ | -24.648% ▲ | $-8.51 ▲ | $-14.297M ▲ |
| Q2-2024 | $225.991M | $85.859M | $-58.63M | -25.944% | $-8.65 | $-31.358M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $145.564M ▲ | $743.689M ▼ | $1.137B ▼ | $-448.784M ▼ |
| Q1-2025 | $145.105M ▲ | $895.68M ▲ | $1.289B ▲ | $-440.741M ▼ |
| Q4-2024 | $93.166M ▼ | $544.383M ▼ | $930.491M ▼ | $-434.688M ▼ |
| Q3-2024 | $118.681M ▼ | $696.783M ▼ | $1.009B ▼ | $-430.399M ▼ |
| Q2-2024 | $142.16M | $897.265M | $1.18B | $-386.405M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.548M ▲ | $-2.826M ▲ | $-8.526M ▼ | $-547K ▲ | $-11.899M ▼ | $-4.453M ▲ |
| Q1-2025 | $-2.329M ▲ | $-21.049M ▲ | $63.176M ▲ | $-2.702M ▲ | $39.425M ▲ | $-22.075M ▲ |
| Q4-2024 | $-47.725M ▲ | $-24.394M ▼ | $2.394M ▲ | $-19.008M ▼ | $-41.008M ▼ | $-25.185M ▼ |
| Q3-2024 | $-56M ▲ | $-21.675M ▲ | $-51K ▲ | $-13.319M ▼ | $-35.045M ▼ | $-22.34M ▲ |
| Q2-2024 | $-57.698M | $-28.431M | $-9.106M | $49.565M | $12.028M | $-29.244M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
| Capitated Revenue | $70.00M ▲ | $120.00M ▲ | $80.00M ▼ | $80.00M ▲ |
| Service Revenue | $10.00M ▲ | $30.00M ▲ | $10.00M ▼ | $10.00M ▲ |
CEO
George Lawrence Mikan III
Compensation Summary
(Year 2024)
CEO
George Lawrence Mikan III
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-05-22 | Reverse | 1:80 |
Price Target
Institutional Ownership
NEA MANAGEMENT COMPANY, LLC
2.727M Shares
$18.415M
DEER MANAGEMENT CO. LLC
999.218K Shares
$6.748M
STEPSTONE GROUP LP
525.247K Shares
$3.547M
VANGUARD GROUP INC
196.217K Shares
$1.325M
REDPOINT MANAGEMENT, LLC
189.623K Shares
$1.281M
GREYCROFT LP
138.352K Shares
$934.291K
BLACKROCK, INC.
113.629K Shares
$767.337K
PARTNERS GROUP HOLDING AG
88.645K Shares
$598.62K
BLACKROCK INC.
78.65K Shares
$531.123K
RENAISSANCE TECHNOLOGIES LLC
56.263K Shares
$379.944K
BLACKSTONE INC.
45.916K Shares
$310.071K
GEODE CAPITAL MANAGEMENT, LLC
35.415K Shares
$239.157K
LEGACY WEALTH ASSET MANAGEMENT, LLC
29.906K Shares
$201.955K
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)
29.182K Shares
$197.066K
UBS GROUP AG
24.967K Shares
$168.602K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
24.894K Shares
$168.109K
NORTHERN TRUST CORP
24.514K Shares
$165.543K
DYNAMIC TECHNOLOGY LAB PRIVATE LTD
19.92K Shares
$134.52K
STATE STREET CORP
12.381K Shares
$83.609K
PATHWAY CAPITAL MANAGEMENT, LP
11.201K Shares
$75.64K
Summary
Only Showing The Top 20